STAAR Surgical Company (STAA) Stock Forecast
STAA analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.55 / 5 from 11 analysts
- Price target
- $28.00 average of analyst targets
- Upside to target
- +31.6% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.05
- 52-week range
- $16.10 – $33.34
STAA analyst ratings
11 analystsNumber of analysts at each rating.
STAA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
STAA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.17 | $0.06 | $0.24 | $0.47 | −64.2% | 7 |
| Current fiscal year (2026) | $0.84 | $0.40 | $1.07 | −$0.17 | +604.6% | 7 |
| Next fiscal year (2027) | $1.11 | $0.77 | $1.42 | $0.84 | +32.3% | 7 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
STAA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $78.7M | $73.2M | $84.6M | −16.9% | 10 |
| Current fiscal year (2026) | $334.3M | $325.5M | $346.6M | +39.6% | 10 |
| Next fiscal year (2027) | $360.6M | $332.0M | $384.7M | +7.9% | 11 |
STAA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
STAA revenue: reported and forecast
STAA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.16 | $0.15 | $0.17 | $0.17 | $0.17 | +7.9% | 0 up · 1 down |
| Current fiscal year (2026) | $0.74 | $0.74 | $0.76 | $0.84 | $0.84 | +14.1% | 3 up · 4 down |
| Next fiscal year (2027) | $0.99 | $0.99 | $1.02 | $1.11 | $1.11 | +12.5% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
STAA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; STAA beat in 8 of 12.
What analysts expect from STAA
11 analysts cover STAAR Surgical; their consensus rating is buy (3.55 on a 1–5 scale, where 5 is a strong buy). The average price target is $28.00, 31.6% above the latest close of $21.27. Analysts expect earnings of $0.84 per share for 2026, +604.6% from a year earlier. For 2027 the average estimate is $1.11 per share on revenue of $360.6 million. STAAR Surgical beat the EPS estimate in 8 of the last 12 quarters.
Related: STAA income statement, STAA key metrics, STAA chart. See the STAA stock overview for the latest quote and news.
STAA forecast FAQ
What is STAAR Surgical's price target?
The average analyst price target for STAAR Surgical is $28.00, 31.6% above the latest close of $21.27.
Is STAAR Surgical a buy, hold or sell?
Of 11 analysts covering STAAR Surgical, 4 rate it a strong buy, 0 a buy, 6 a hold, 0 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is STAAR Surgical's EPS forecast?
Analysts forecast $0.84 per share for 2026 (range $0.40 to $1.07); for 2027 the estimate is $1.11.
What is STAAR Surgical's revenue forecast?
The average revenue estimate for 2026 is $334.3 million, growth of 39.6%; for 2027 it is $360.6 million.
When does STAAR Surgical report earnings?
STAAR Surgical is expected to report results for the quarter ending September 30, 2026 on November 4, 2026; the EPS estimate is $0.05.
Does STAAR Surgical usually beat earnings estimates?
STAAR Surgical reported EPS at or above the analyst estimate in 8 of the last 12 quarters.